Senior Editor Markus Elsner talks to Alex Marson of UCSF about the significance of a Science paper describing the phase 1 clinical trial of CRISPR-engineered T cells. The work was carried out by a team led by Carl June and Edward Stadtmauer from UPenn. Read the paper at https://doi.org/10.1126/science.aba7365.
Rights and permissions
About this article
Cite this article
Forum: First human trial of engineered T cells. Nat Biotechnol 38, 699 (2020). https://doi.org/10.1038/s41587-020-0544-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-020-0544-x
